Waters Corporation WAT
Set alert
As of Nov 2, 2:23 PM ET
- YTD
- +19.23%
- 1 year
- +29.54%
- Open
- 463.67
- Prev close
- 462.72
- Mkt cap
- 44.48B
- Vol
- 1.04M
- Avg vol
- 813.45K
- EPS
- 3.95
- P/E
- 114.69
- Div yield
- 0.00%
More statistics
- Low
- 449.46
- High
- 466.45
- Forward P/E
- 27.96
- Beta
- 1.15
- Short ratio
- 3.72
- Inst. own
- 102.21%
- Dividend
- 0.00
- Ex-div date
- Nov 25, 1996
- Earnings
- Nov 3, 2026
- 50-d avg
- 429.02
- 200-d avg
- 369.17
- 1y target
- 465.86
5Y chart
Events in this range
- Aug 4, 2025Earnings: 2.95; estimate 2.94; surprise 0.34%
- Nov 4, 2025Earnings: 3.4; estimate 3.21; surprise 5.92%
- Feb 9, 2026Earnings: 4.53; estimate 4.51; surprise 0.44%
- May 5, 2026Earnings: 2.7; estimate 2.31; surprise 16.88%
- Aug 4, 2026Earnings: 3.05; estimate 3.01; surprise 1.33%
- Aug 27, 2026Rating: Piper Sandler · Neutral → Overweight
- Sep 9, 2026Rating: UBS · Neutral → Buy
- Sep 21, 2026Rating: Goldman Sachs · Buy → Buy
- Oct 1, 2026Rating: Guggenheim · Buy → Buy
- Oct 7, 2026Rating: Barclays · Overweight → Overweight
- Oct 13, 2026Rating: TD Cowen · Buy → Buy
- Nov 3, 2026Earnings: —; estimate 4; surprise —%
Signals (84)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 22, 2025 | 1 year ago |
| SMA: Bullish | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Jul 14, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 14, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 9, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bearish | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| SMA: Bullish | Mar 3, 2025 | 1 year ago |
| SMA: Bearish | Feb 10, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 13, 2025 | 1 year ago |
| SMA: Bullish | Jan 6, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 6, 2025 | 1 year ago |
| SMA: Bearish | Dec 30, 2024 | 1 year ago |
| SMA: Bullish | Dec 23, 2024 | 1 year ago |
| SMA: Bearish | Dec 16, 2024 | 1 year ago |
| SMA: Bullish | Oct 28, 2024 | 2 years ago |
| SMA: Bullish | Oct 28, 2024 | 2 years ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| SMA: Bullish | Sep 16, 2024 | 2 years ago |
| SMA: Bearish | Sep 9, 2024 | 2 years ago |
| SMA: Bullish | Jul 29, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 29, 2024 | 2 years ago |
| SMA: Bullish | Jul 22, 2024 | 2 years ago |
| SMA: Bearish | May 27, 2024 | 2 years ago |
| SMA: Bearish | May 27, 2024 | 2 years ago |
| SMA: Bullish | May 6, 2024 | 2 years ago |
| SMA: Bullish | Apr 22, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 8, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| RSI: Overbought | Mar 4, 2024 | 2 years ago |
| SMA: Bullish | Nov 20, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 20, 2023 | 2 years ago |
| SMA: Bullish | Nov 13, 2023 | 2 years ago |
| MACD: Sell Signal | Oct 9, 2023 | 3 years ago |
| SMA: Bearish | Sep 4, 2023 | 3 years ago |
| SMA: Bullish | Aug 28, 2023 | 3 years ago |
| SMA: Bearish | Aug 14, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 17, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| RSI: Oversold | Jun 5, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| SMA: Bullish | Feb 27, 2023 | 3 years ago |
| SMA: Bearish | Feb 20, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 20, 2023 | 3 years ago |
| SMA: Bearish | Feb 6, 2023 | 3 years ago |
| SMA: Bullish | Jan 30, 2023 | 3 years ago |
| SMA: Bearish | Jan 23, 2023 | 3 years ago |
| SMA: Bullish | Jan 9, 2023 | 3 years ago |
| SMA: Bearish | Jan 2, 2023 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 7, 2022 | 3 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 22, 2022 | 4 years ago |
| SMA: Bearish | Aug 8, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bearish | Jun 13, 2022 | 4 years ago |
| SMA: Bearish | Jun 13, 2022 | 4 years ago |
| SMA: Bullish | May 2, 2022 | 4 years ago |
| SMA: Bearish | Mar 28, 2022 | 4 years ago |
| SMA: Bullish | Mar 14, 2022 | 4 years ago |
Key statistics
- Market cap
- 45.43B
- Enterprise value
- 52.10B
- Trailing P/E
- 117.15
- Forward P/E
- 27.96
- PEG ratio
- 1.79
- Price / sales
- 9.78
- Price / book
- 2.99
- EPS (TTM)
- 3.95
- Beta
- 1.15
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 3.59%
- Revenue (TTM)
- 4.64B
- Revenue growth
- 113.40%
- Free cash flow
- -142.07M
- Total cash
- 539.00M
- Total debt
- 5.48B
- Return on equity
- 1.92%
- Shares outstanding
- 98.19M
- Short % of float
- 3.25%
- 50-day average
- 429.02
- 200-day average
- 369.17
Analyst view
Consensus: buy
- Target (low)
- 349.00
- Target (mean)
- 465.86
- Target (high)
- 530.00
- Strong buy3
- Buy15
- Hold4
- Sell0
- Strong sell1
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate 4.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Oct 4, 2026 | 4.00 | — | — | — |
| Aug 4, 2026 | Jul 4, 2026 | 3.01 | 3.05 | +0.04 | +1.33% |
| May 5, 2026 | Apr 4, 2026 | 2.31 | 2.70 | +0.39 | +16.88% |
| Feb 9, 2026 | Dec 31, 2025 | 4.51 | 4.53 | +0.02 | +0.44% |
| Nov 4, 2025 | Sep 27, 2025 | 3.21 | 3.40 | +0.19 | +5.92% |
| Aug 4, 2025 | Jun 28, 2025 | 2.94 | 2.95 | +0.01 | +0.34% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | main | Buy | Buy |
| Oct 7, 2026 | Barclays | main | Overweight | Overweight |
| Oct 1, 2026 | Guggenheim | main | Buy | Buy |
| Sep 21, 2026 | Goldman Sachs | main | Buy | Buy |
| Sep 9, 2026 | UBS | up | Neutral | Buy |
| Aug 27, 2026 | Piper Sandler | up | Neutral | Overweight |
About Waters Corporation
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Website
- waters.com
News
- Here’s How Much You Would Have Made Owning Waters Stock In The Last 20 Years
- Waters Gears Up to Report Q3 Results: How to Play the Stock?
- Waters Launches AI-Powered Peak Integration Expanding its Suite of Premium AI Subscription Capabilities for Empower Software
- Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests
- First Eagle U.S. Value Fund Q3 2026 Portfolio Review
- Waters And Labcorp To Expand Access To BD Onclarity HPV Assay
- Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026
- Waters Launches AI Link to Advance AI-Enabled LC-MS Workflows
- Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option
- Two stocks poised to benefit from rotation out of AI
Your note
Sign in to keep a note on WAT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BATRA UDIT | Chief Executive Officer | Stock Award(Grant) | Feb 24, 2026 | 36,557 |
| BENNETT JIANQING | Officer | Stock Award(Grant) | Feb 24, 2026 | 7,244 |
| CARPIO ROBERT L III | Officer | Stock Award(Grant) | Feb 24, 2026 | 3,615 |
| CHAUBAL AMOL | Chief Financial Officer | Stock Award(Grant) | Feb 24, 2026 | 8,505 |
| FEARON RICHARD H | Director | Purchase | Mar 5, 2026 | 3,302 |
| HUANG PEARL S. | Director | Stock Award(Grant) | Feb 24, 2026 | 3,276 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.64% | 8,484,939 | 3.93B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.53% | 6,415,552 | 2.97B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.83% | 4,740,524 | 2.19B | Jun 29, 2026 |
| Massachusetts Financial Services Co. | 4.71% | 4,625,035 | 2.14B | Jun 29, 2026 |
| State Street Corporation | 4.46% | 4,382,008 | 2.03B | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 3.89% | 3,817,779 | 1.77B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 3,116,340 | 1.44B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 2,545,419 | 1.18B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.17% | 2,127,547 | 984.47M | Jun 29, 2026 |
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 2.14% | 2,101,625 | 972.47M | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 1,309,174 | 605.79M | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.30% | 1,274,542 | 589.76M | Aug 30, 2026 |